1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Hyperthyroxinemia: new trials by email Literature Review of Hyperthyroxinemia trials Research Report on Hyperthyroxinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients Placebo, Resmetirom - Non-Alcoholic Fatty Liver Disease | Phase 3 | Completed | Madrigal Pharmaceuticals, Inc. | 1343 | 2019-12-16 | 2023-09-05 |
Dyslipidemias (1) · Fibrosis (1) · Hyperlipidemias (1) · Non-alcoholic Fatty Liver Disease (1) · Thyroid Hormone Resistance Syndrome (1)
Digestive System Diseases (1) · Endocrine System Diseases (1) · Fatty Liver (1) · Lipid Metabolism Disorders (1) · Liver Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Thyroid Diseases (1)
resmetirom (1)
Madrigal Pharmaceuticals, Inc. (1)
Puerto Rico (1) · United States (1)
Rebecca Taub, MD (1)